Equity Overview
Price & Market Data
Price: $0.272
Daily Change: -$0.0₃27 / 0.10%
Daily Range: $0.243 - $0.273
Market Cap: $6,570,774
Daily Volume: 2,741,254
Performance Metrics
1 Week: -9.03%
1 Month: -18.50%
3 Months: -54.28%
6 Months: -89.28%
1 Year: -94.64%
YTD: -85.68%
Company Details
Employees: 16
Sector: Health technology
Industry: Biotechnology
Country:
Details
Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.